There are many synthetic peptides, and the number is growing
Longevity pathway activation NAD+ plays a crucial role in activating sirtuins, a family of proteins involved in cellular repair, stress response, and aging
PLK1-inhibition can cause radiosensitization or radioresistance dependent on the treatment schedule
Skeletal localization of samarium-153 chelates: potential therapeutic bone agents
OASIS trials: establishing effective doses Phase 2 OASIS 1 findings: Tested multiple dose levels: 0.3mg, 0.6mg, 1.2mg, 2.4mg, 4.5mg weekly Duration: 26 weeks Primary endpoint: Weight loss at each dose Dose-response results: 0.3mg weekly: ~4% body weight loss 0.6mg weekly: ~6% body weight loss 1.2mg weekly: ~8% body weight loss 2.4mg weekly: ~10% body weight loss 4.5mg weekly: ~12% body weight loss Key insight: Clear dose-response relationship
The scientific literature reveals that while copper-containing peptides can theoretically catalyze oxidation of susceptible amino acids in adjacent molecules, the actual risk depends entirely on substrate availability